Promazine Hydrochloride

盐酸丙嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePromazine Hydrochloride
Drug Alias Name丙嗪盐酸盐盐酸普马嗪SparineTalofenWY-1094
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsMental Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/04/13
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHikma
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN05AA03
Related LinksN/A